Potential Treatment of Herpes Simplex Vi
✍
Kenneth H. Rand; Nicholas Bodor; Alaaeldin A. Ei Koussi; Issam Raad; Dr. Akio Mi
📂
Article
📅
1986
🏛
John Wiley and Sons
🌐
English
⚖ 448 KB
A newly described, drug-carrier delivery system in which a lipophilic derivative is enzymatically converted to a hydrophilic compound was used to treat experimental herpes simplex virus (HSV) encephalitis. Because trifluorothymidine (TFT) does not cross the blood brain barrier, the lipophilic dihydr